SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RNAi -- Ignore unavailable to you. Want to Upgrade?

To: Thomas who wrote (405)8/9/2005 12:13:18 PM
From: keokalani'nui  Respond to of 671
 
Thomas,

I really don't know. I am not making much of a bet at all on sRNAi. The problem with all these dna/rna/oligo companies is they break your heart after P2. Rapture until doom.

If they can get what they want to where they want it and nowhere else, then I think they are undervalued. But based on history, after billions in clinical failure the first drug that will probably succeed is a topical cream for freckles in 2015. <g>

Opinion could change in an instant.

W



To: Thomas who wrote (405)8/10/2005 9:22:37 AM
From: AJ Berger  Respond to of 671
 
missed earnings buying opportunity

A lot of very positive information in the conference call despite missing earnings by 2c was overlooked by after hours traders. I will be taking an initial long term position in this stock at the open which should return to the $4.50 range by week end.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News